Eosinophil activation in ulcerative colitis -: Studies on mucosal release and localization of eosinophil granule constituents

被引:77
作者
Raab, Y [1 ]
Fredens, K
Gerdin, B
Hällgren, R
机构
[1] Univ Uppsala Hosp, Dept Surg, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Plast Surg, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Internal Med, S-75185 Uppsala, Sweden
[4] Univ Aarhus, Dept Neurobiol, Aarhus, Denmark
关键词
ulcerative colitis; eosinophils; neutrophils; eosinophil cationic protein; intestinal perfusion; immunohistochemistry;
D O I
10.1023/A:1018843104511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Activation of eosinophil granulocytes (eosinophils) seems to contribute to the pathophysiology of several inflammatory conditions. This process was evaluated in 18 patients with ulcerative colitis and in 18 healthy controls using intraluminal segmental perfusion of the sigmoid colon and rectum and immunoanalysis for eosinophil cationic protein (ECP) in the perfusate. Immunohistochemistry for eosinophils and neutrophils was made in simultaneously taken biopsies and in biopsies from surgical specimens taken from additional 10 patients. The mucosal release of ECP was increased severalfold in patients with UC. The bowel biopsies demonstrated a lamina propria infiltrated with eosinophils. The degree of eosinophil activation/degranulation was related to the intensity of the inflammatory reaction. Activated eosinophils and extracellular deposits of ECP were, in particular, seen in crypt abscesses and in areas with damaged surface epithelium. Since ECP is highly cytotoxic, its release at the site of inflammatory bowel lesions might reflect a potential pathophysiological mechanism.
引用
收藏
页码:1061 / 1070
页数:10
相关论文
共 35 条
[1]
PHAGOCYTES IN CELL-SUSPENSIONS OF HUMAN-COLON MUCOSA [J].
BEEKEN, W ;
NORTHWOOD, I ;
BELIVEAU, C ;
GUMP, D .
GUT, 1987, 28 (08) :976-980
[2]
EOSINOPHILS OF HUMAN COLONIC MUCOSA - C3B AND FC-GAMMA RECEPTOR EXPRESSION AND PHAGOCYTIC CAPABILITIES [J].
BEEKEN, WL ;
NORTHWOOD, I ;
BELIVEAU, C ;
BAIGENT, G ;
GUMP, D .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 43 (03) :289-300
[3]
BERSTAD A, 1993, HEPATO-GASTROENTEROL, V40, P276
[4]
BINDER V, 1970, SCAND J GASTROENTERO, V5, P627
[5]
ACTIVATED EOSINOPHILS IN CHRONIC INFLAMMATORY BOWEL-DISEASE [J].
CHOY, MY ;
WALKERSMITH, JA ;
WILLIAMS, CB ;
MACDONALD, TT .
LANCET, 1990, 336 (8707) :126-127
[6]
RAISED CIRCULATING LEVELS OF THE EOSINOPHIL CATIONIC PROTEIN IN ANKYLOSING-SPONDYLITIS - RELATION WITH THE INFLAMMATORY ACTIVITY AND THE INFLUENCE OF SULFASALAZINE TREATMENT [J].
FELTELIUS, N ;
HALLGREN, R ;
VENGE, P .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (05) :403-407
[7]
GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115
[8]
GLEICH GJ, 1986, ADV IMMUNOL, V39, P177
[9]
GLEICH GJ, 1979, J IMMUNOL, V123, P2925
[10]
COMPARATIVE PROPERTIES OF CHARCOT-LEYDEN CRYSTAL PROTEIN AND MAJOR BASIC-PROTEIN FROM HUMAN EOSINOPHILS [J].
GLEICH, GJ ;
LOEGERING, DA ;
MANN, KG ;
MALDONADO, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (03) :633-640